Document Detail

Enhanced phosphorylation-independent arrestins and gene therapy.
MedLine Citation:
PMID:  24292828     Owner:  NLM     Status:  In-Data-Review    
A variety of heritable and acquired disorders is associated with excessive signaling by mutant or overstimulated GPCRs. Since any conceivable treatment of diseases caused by gain-of-function mutations requires gene transfer, one possible approach is functional compensation. Several structurally distinct forms of enhanced arrestins that bind phosphorylated and even non-phosphorylated active GPCRs with much higher affinity than parental wild-type proteins have the ability to dampen the signaling by hyperactive GPCR, pushing the balance closer to normal. In vivo this approach was so far tested only in rod photoreceptors deficient in rhodopsin phosphorylation, where enhanced arrestin improved the morphology and light sensitivity of rods, prolonged their survival, and accelerated photoresponse recovery. Considering that rods harbor the fastest, as well as the most demanding and sensitive GPCR-driven signaling cascade, even partial success of functional compensation of defect in rhodopsin phosphorylation by enhanced arrestin demonstrates the feasibility of this strategy and its therapeutic potential.
Vsevolod V Gurevich; Xiufeng Song; Sergey A Vishnivetskiy; Eugenia V Gurevich
Related Documents :
3025528 - Structure-activity relationships of aromatic retinoids on the differentiation of the hu...
7840778 - Modulation of mu opioid binding by protein kinase inhibitors.
1676428 - Tyrphostins. 2. heterocyclic and alpha-substituted benzylidenemalononitrile tyrphostins...
15050628 - Evans blue and other dyes as protein tyrosine phosphatase inhibitors.
18068678 - Multimerisation of receptor-type protein tyrosine phosphatases ptpbr7 and ptp-sl attenu...
23723008 - Inhibition of mlc20 phosphorylation downstream of ca(2+) and rhoa: a novel mechanism in...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Handbook of experimental pharmacology     Volume:  219     ISSN:  0171-2004     ISO Abbreviation:  Handb Exp Pharmacol     Publication Date:  2014  
Date Detail:
Created Date:  2013-12-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7902231     Medline TA:  Handb Exp Pharmacol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  133-52     Citation Subset:  IM    
Department of Pharmacology, Vanderbilt University, 2200 Pierce Avenue, Nashville, TN, 37232, USA,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cone arrestin: deciphering the structure and functions of arrestin 4 in vision.
Next Document:  Targeting Individual GPCRs with Redesigned Nonvisual Arrestins.